Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?

Ann Hematol. 2023 Oct;102(10):2963-2964. doi: 10.1007/s00277-023-05329-9. Epub 2023 Jul 19.

Authors

Alice Di Rocco¹, Martina Di Palma², Gianna Maria D'Elia², Giovanni Iaquinta³, Massimo Breccia², Francesca Mancini², Paola Grammatico³, Maurizio Martelli²

Affiliations

¹ Department of Translational and Precision Medicine, Sapienza University, Via Benevento 6, 00161, Rome, Italy. dirocco@bce.uniroma1.it.
² Department of Translational and Precision Medicine, Sapienza University, Via Benevento 6, 00161, Rome, Italy.
³ U.O.C. Medical Genetics Laboratory, Department of Experimental Medicine, San Camillo Forlanini Hospital - Sapienza University, Rome, Italy.

PMID: 37468670
DOI: 10.1007/s00277-023-05329-9

No abstract available

Publication types

Letter

MeSH terms

Cell- and Tissue-Based Therapy
Clone Cells
Humans
Immunotherapy, Adoptive / adverse effects
Receptors, Antigen, T-Cell / genetics
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen
Receptors, Antigen, T-Cell